Companies

Search, filter and compare every US company we cover.

Search companies

Sector

Industry

Size

Today

Profitable Growing

Add filter

Clear all

916 companies match

Sort by

Market cap

Highest first

Company	Industry	Market cap	Price	Day change	Revenue	Revenue growth	Operating margin	P/E	5-yr growth	Gross margin	Net margin	Free cash flow	FCF margin	Return on capital	Return on equity	Net debt	Net debt / EBITDA	Dividends + buybacks	Share count change	F-score	Insider buys (90d)	Insider sales (90d)
Liquidia CorpLQDA	Pharmaceutical Preparations	$4.6B	$45.44	3.9%	$158M	1,031.2%	−32.5%	32.5x	192.5%	—	−43.5%	−$40.0M	−25.3%	—	−111.1%	—	—	—	9.3%	3	$0.0M	$25.7M
LivaNovaLIVN	Health Care Equipment	$4.5B	$80.38	0.3%	$1.4B	10.7%	14.4%	23.8x	8.2%	67.7%	−17.5%	$173M	12.5%	12.8%	−19.2%	−$260M	—	$0.0M	−0.1%	5	$0.0M	$0.8M
Dianthus Therapeutics, Inc. /DE/DNTH	Pharmaceutical Preparations	$4.5B	$79.52	0.2%	$2.0M	−67.3%	−8,739.3%	—	—	—	−7,973.3%	—	—	—	−38.4%	—	—	—	15.9%	1	$0.0M	$26.1M
Adaptive Biotechnologies CorpADPT	Biological Products, (No Diagnostic Substances)	$4.4B	$27.66	5.3%	$277M	54.8%	−20.6%	—	23.0%	74.2%	−21.5%	−$48.9M	−17.7%	−36.7%	−28.2%	−$95.8M	—	—	3.1%	5	$0.0M	$28.9M
DBV Technologies S.A.DBVT	Biological Products, (No Diagnostic Substances)	$4.4B	$10.13	1.5%	$5.6M	35.8%	−2,609.2%	—	−13.0%	—	−2,607.3%	−$122M	−2,159.6%	—	−149.8%	—	—	—	43.9%	3	$0.0M	$0.0M
IntegerITGR	Health Care Equipment	$4.3B	$126.74	0.2%	$1.9B	8.0%	11.9%	34.7x	11.6%	27.0%	5.6%	$105M	5.7%	6.6%	6.1%	$1.2B	3.4x	$50.0M	−0.2%	7	$0.0M	$5.2M
IndiviorINDV	Pharmaceuticals	$4.3B	$34.72	0.5%	$1.2B	4.3%	21.2%	12.4x	—	80.2%	17.0%	−$93.0M	−7.5%	—	—	$124M	0.5x	$11.0M	−3.8%	4	$0.1M	$0.0M
Arcutis Biotherapeutics, Inc.ARQT	Pharmaceutical Preparations	$4.3B	$31.68	0.4%	$376M	91.3%	−3.3%	144.0x	—	90.2%	−4.3%	−$6.3M	−1.7%	−12.5%	−9.3%	−$112M	—	—	5.2%	4	$0.0M	$2.3M
Edgewise Therapeutics, Inc.EWTX	Pharmaceutical Preparations	$4.3B	$39.53	0.9%	—	—	—	—	—	—	—	−$144M	—	—	−34.2%	—	—	—	11.4%	—	$0.0M	$1.9M
CorVelCRVL	Health Care Services	$4.2B	$82.67	2.3%	$959M	7.0%	—	36.7x	11.6%	24.3%	11.5%	$110M	11.5%	—	30.8%	—	—	$56.2M	−0.7%	—	$0.0M	$16.3M
Veracyte, Inc.VCYT	Services-Medical Laboratories	$4.1B	$50.28	4.3%	$517M	16.0%	11.2%	35.9x	34.5%	70.1%	12.8%	$127M	24.5%	—	5.3%	—	—	—	3.1%	7	$0.0M	$1.4M
Definium Therapeutics, Inc.DFTX	Medicinal Chemicals & Botanical Products	$4.1B	$37.08	3.9%	—	—	—	—	—	—	—	—	—	—	−64.1%	−$371M	—	—	26.8%	1	$0.0M	$3.0M
ICU MedicalICUI	Health Care Supplies	$4.1B	$163.20	1.7%	$2.2B	−6.3%	1.9%	137.1x	11.9%	36.8%	0.0%	$91.8M	4.1%	0.7%	0.0%	$983M	4.0x	$8.8M	2.1%	6	$0.0M	$6.6M
iRhythm Holdings, Inc.IRTC	Surgical & Medical Instruments & Apparatus	$4.1B	$123.75	1.5%	$747M	26.2%	−7.7%	—	23.0%	70.6%	−6.0%	$34.5M	4.6%	—	−36.6%	—	—	$0.0M	2.6%	5	$0.0M	$7.4M
AbCellera Biologics Inc.ABCL	Pharmaceutical Preparations	$3.9B	$12.83	6.2%	$75.1M	160.6%	−289.0%	—	−20.3%	—	−194.9%	−$174M	−231.7%	—	−14.5%	—	—	—	1.5%	4	$1.5M	$0.0M
EnvistaNVST	Health Care Supplies	$3.9B	$23.58	0.3%	$2.7B	8.3%	8.0%	40.7x	7.1%	54.7%	1.7%	$230M	8.5%	3.2%	1.6%	$237M	0.7x	$167M	−1.7%	7	$0.0M	$0.2M
CareDx, Inc.CDNA	Services-Medical Laboratories	$3.8B	$70.53	2.1%	$380M	13.8%	−8.1%	34.1x	14.6%	—	−5.6%	—	—	—	−6.3%	—	—	$87.8M	−5.9%	4	$0.0M	$3.9M
Celcuity Inc.CELC	Services-Medical Laboratories	$3.7B	$68.07	3.4%	—	—	—	—	—	—	—	−$154M	—	—	−163.8%	−$304M	—	—	18.5%	4	$0.0M	$0.0M
Organon & Co.OGN	Pharmaceutical Preparations	$3.7B	$13.75	0.1%	$6.2B	−2.9%	—	17.6x	−1.0%	53.3%	3.0%	$538M	8.7%	—	30.6%	$8.1B	—	$88.0M	0.6%	5	$0.0M	$0.2M
Denali Therapeutics Inc.DNLI	Biological Products, (No Diagnostic Substances)	$3.6B	$19.22	3.0%	$0.0M	—	—	—	—	—	—	−$422M	—	—	−45.7%	—	—	—	5.0%	2	$0.0M	$0.4M
Xenon Pharmaceuticals Inc.XENE	Pharmaceutical Preparations	$3.6B	$36.01	0.7%	$7.5M	—	−4,974.3%	—	−25.3%	—	−4,612.1%	−$280M	−3,732.2%	—	−51.8%	—	—	—	1.7%	2	$1.7M	$1.1M
Acadia PharmaceuticalsACAD	Pharmaceuticals	$3.5B	$20.17	2.2%	$1.1B	11.9%	9.8%	9.0x	19.4%	91.7%	36.5%	$105M	9.8%	—	39.9%	—	—	$0.0M	2.1%	—	$0.0M	$1.0M
Tango Therapeutics, Inc.TNGX	Pharmaceutical Preparations	$3.4B	$22.89	3.1%	$62.4M	48.3%	−178.4%	—	52.1%	—	−162.9%	−$140M	−224.3%	—	−37.2%	—	—	—	6.4%	3	$0.0M	$2.2M
National Healthcare CorpNHC	Services-Skilled Nursing Care Facilities	$3.4B	$211.81	5.3%	$1.5B	16.1%	8.5%	23.8x	8.1%	—	7.9%	$149M	9.8%	9.5%	11.7%	−$52.8M	−0.3x	$53.4M	0.3%	7	$0.0M	$5.6M
Gossamer Bio, Inc.GOSS	Pharmaceutical Preparations	$3.2B	$9.77	6.8%	$48.5M	−57.7%	−352.2%	—	—	—	−351.5%	−$171M	−353.5%	—	—	—	—	—	1.0%	0	$0.0M	$0.0M
Amylyx Pharmaceuticals, Inc.AMLX	Pharmaceutical Preparations	$3.1B	$28.30	4.5%	$0.0M	−100.0%	—	—	—	—	—	−$123M	—	—	−61.6%	—	—	—	38.8%	3	$0.0M	$3.8M
Nurix Therapeutics, Inc.NRIX	Pharmaceutical Preparations	$3.1B	$26.70	4.5%	$84.0M	54.0%	−340.2%	11.6x	36.3%	—	−314.9%	−$263M	−313.7%	—	−49.6%	—	—	—	29.1%	3	$0.0M	$1.8M
Disc Medicine, Inc.IRON	Pharmaceutical Preparations	$3.1B	$79.90	2.9%	—	—	—	—	—	—	—	−$181M	—	—	−35.9%	−$762M	—	—	27.9%	3	$0.0M	$13.6M
IDEAYA Biosciences, Inc.IDYA	Pharmaceutical Preparations	$3.1B	$33.50	1.9%	$219M	3,024.4%	−72.8%	—	62.1%	—	−52.0%	−$73.5M	−33.6%	—	−10.9%	—	—	—	8.3%	3	$0.0M	$1.0M
Tarsus Pharmaceuticals, Inc.TARS	Biological Products, (No Diagnostic Substances)	$3.1B	$70.76	1.0%	$451M	146.7%	−15.7%	—	—	—	−14.7%	−$22.3M	−4.9%	—	−23.4%	−$345M	—	—	11.1%	4	$0.0M	$5.2M
Surgery Partners, Inc.SGRY	Services-General Medical & Surgical Hospitals, Nec	$3.0B	$23.36	0.5%	$3.3B	6.2%	11.8%	—	12.2%	—	−2.4%	$196M	5.9%	6.3%	−4.4%	$4.4B	7.8x	—	0.9%	5	$0.1M	$0.0M
AtriCure, Inc.ATRC	Surgical & Medical Instruments & Apparatus	$3.0B	$61.51	0.7%	$535M	14.9%	−1.8%	—	20.9%	75.0%	−2.1%	$48.3M	9.0%	−1.9%	−2.4%	−$98.3M	−37.2x	—	1.7%	7	$0.0M	$1.9M
Viking Therapeutics, Inc.VKTX	Pharmaceutical Preparations	$2.9B	$24.89	2.8%	$0.0M	—	—	—	—	—	—	—	—	—	−47.3%	—	—	—	3.3%	1	$0.0M	$0.0M
Enliven Therapeutics, Inc.ELVN	Pharmaceutical Preparations	$2.9B	$43.69	5.3%	—	—	—	—	—	—	—	−$70.5M	—	—	−27.0%	—	—	—	20.4%	—	$0.0M	$11.8M
Privia Health Group, Inc.PRVA	Services-Health Services	$2.9B	$21.83	1.5%	$2.1B	22.3%	1.6%	99.2x	21.0%	—	1.1%	—	—	—	3.3%	—	—	—	2.6%	5	$0.0M	$0.0M
Aveanna Healthcare Holdings, Inc.AVAH	Services-Home Health Care Services	$2.9B	$12.70	3.6%	$2.4B	20.2%	10.5%	10.1x	10.2%	33.3%	9.2%	—	—	19.7%	634.7%	$1.1B	4.1x	—	11.4%	6	$0.0M	$340M
TransMedics Group, Inc.TMDX	Electromedical & Electrotherapeutic Apparatus	$2.8B	$69.73	1.3%	$605M	37.1%	17.9%	18.1x	88.2%	59.9%	31.4%	$134M	22.1%	—	54.2%	−$479M	−3.5x	—	15.1%	6	$0.1M	$0.0M
Silence Therapeutics plcSLN	Pharmaceutical Preparations	$2.8B	$19.78	0.0%	$0.6M	−98.7%	−16,292.8%	—	—	61.5%	−15,851.9%	−$62.3M	−11,149.6%	—	−90.3%	—	—	—	2.1%	1	$0.0M	$0.0M
Dyne Therapeutics, Inc.DYN	Pharmaceutical Preparations	$2.8B	$16.94	7.8%	—	—	—	—	—	—	—	−$405M	—	−3,526.6%	−55.7%	−$962M	—	—	36.4%	3	$0.0M	$65.7M
Neogen CorpNEOG	In Vitro & In Vivo Diagnostic Substances	$2.7B	$12.47	2.1%	$870M	−2.7%	−2.5%	—	13.2%	46.9%	−0.9%	$31.9M	3.7%	−0.6%	−0.4%	$608M	6.4x	—	0.3%	6	$0.0M	$0.0M
Acadia HealthcareACHC	Health Care Facilities	$2.7B	$29.90	4.6%	$3.3B	5.0%	—	—	9.7%	—	−33.3%	−$440M	−13.3%	−16.0%	−43.9%	$2.4B	—	$50.0M	−1.5%	4	$0.0M	$0.0M
Beam Therapeutics Inc.BEAM	Biological Products, (No Diagnostic Substances)	$2.6B	$24.90	4.7%	$140M	120.0%	−274.6%	—	466.3%	—	−57.2%	−$360M	−257.7%	—	−8.1%	—	—	—	20.2%	3	$0.0M	$1.2M
ADMA BiologicsADMA	Biotechnology	$2.6B	$11.17	0.9%	$510M	19.6%	37.5%	16.0x	64.6%	57.4%	28.8%	$27.8M	5.5%	39.5%	35.6%	−$15.5M	−0.1x	$31.9M	0.6%	5	$0.0M	$0.0M
Precigen, Inc.PGEN	Pharmaceutical Preparations	$2.5B	$6.15	1.8%	$9.7M	146.7%	−1,141.1%	—	−21.3%	—	−2,588.2%	−$89.8M	−927.6%	−538.0%	−843.6%	−$4.7M	—	—	16.9%	2	$0.0M	$3.4M
NewAmsterdam Pharma Co N.V.NAMS	Pharmaceutical Preparations	$2.5B	$20.50	5.0%	$22.5M	−50.6%	−1,002.9%	—	—	—	−905.7%	−$148M	−657.8%	—	−28.3%	—	—	—	25.5%	2	$0.2M	$4.7M
MBX Biosciences, Inc.MBX	Pharmaceutical Preparations	$2.5B	$52.97	5.3%	—	—	—	—	—	—	—	−$81.9M	—	—	−27.8%	—	—	—	243.0%	—	$0.0M	$0.0M
Bausch Health CompaniesBHC	Pharmaceuticals	$2.4B	$6.31	0.6%	$10.3B	6.7%	17.7%	—	5.0%	—	1.5%	$1.0B	9.8%	4.5%	—	$19.5B	6.5x	$0.0M	1.9%	7	$0.0M	$0.3M
Supernus Pharmaceuticals, Inc.SUPN	Pharmaceutical Preparations	$2.4B	$40.96	0.5%	$719M	8.6%	−8.7%	—	6.7%	89.6%	−5.4%	$46.0M	6.4%	—	−3.7%	—	—	—	0.9%	4	$0.0M	$0.0M
Pediatrix Medical Group, Inc.MD	Services-Hospitals	$2.3B	$28.84	0.7%	$1.9B	−4.9%	10.9%	13.8x	2.0%	—	8.6%	—	—	16.6%	20.3%	$101M	0.4x	$86.7M	2.5%	6	$0.0M	$0.0M
Celldex Therapeutics, Inc.CLDX	In Vitro & In Vivo Diagnostic Substances	$2.3B	$30.15	2.2%	$1.5M	−78.0%	−18,599.8%	—	−26.9%	87.1%	−16,748.0%	−$214M	−13,829.1%	—	−40.6%	—	—	—	3.1%	1	$0.0M	$0.0M

What do these columns mean?

Market cap: Last close times the latest diluted share count, so it is approximate.
Price: Closing share price on the last trading day.
Day change: Change in the closing price against the previous trading day's close.
Revenue: Total sales reported in the income statement.
Revenue growth: Change in revenue against the year (or quarter) a year earlier.
Operating margin: Operating income as a share of revenue.
P/E: Last close divided by diluted earnings per share over the last four quarters.
5-yr growth: Revenue growth a year, compounded over the last five years.
Gross margin: Gross profit as a share of revenue.
Net margin: Net income as a share of revenue.
Free cash flow: Cash from operations minus capital spending.
FCF margin: Free cash flow as a share of revenue.
Return on capital: After-tax operating income as a share of the money invested in the business: debt plus equity, minus cash.
Return on equity: Net income as a share of average shareholders' equity.
Net debt: Debt and finance leases minus cash and short-term investments. Negative means net cash.
Net debt / EBITDA: Years of EBITDA needed to pay off net debt. Below zero means more cash than debt.
Dividends + buybacks: Cash returned to shareholders through dividends and share repurchases.
Share count change: Change in the diluted share count. Negative means buybacks shrank it.
F-score: Nine pass/fail tests of profitability, funding and efficiency. 8–9 is strong, 0–2 weak.
Industry: The industry the company reports under, from its SEC filing code. Click it to see its peers.
Colours and dashes: Green is up or growing, red is down or shrinking. — means no data, or a P/E that is not meaningful (losses, or above 200).
Units: M = millions, B = billions, T = trillions, in USD. Fundamentals use the latest fiscal year. Use “Edit columns” to show more figures, hide some or change their order.